Peptide-Mediated Delivery of CRISPR Enzymes for the Efficient Editing of Primary Human Lymphocytes

Scientists showed that the yields of edited primary human lymphocytes could be increased substantially by delivering a CRISPR ribonucleoprotein mixed with an amphiphilic peptide identified through screening.